Target Gene Table ▼
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44027609HTLV-1ENSG00000131196.18protein_codingNFATC1NoNo4772F5H4S8
O95644
TVIS44003530HTLV-1ENSG00000131196.18protein_codingNFATC1NoNo4772F5H4S8
O95644
TVIS44027610HTLV-1ENSG00000131196.18protein_codingNFATC1NoNo4772F5H4S8
O95644
TVIS44023964HTLV-1ENSG00000131196.18protein_codingNFATC1NoNo4772F5H4S8
O95644
TVIS44004519HTLV-1ENSG00000131196.18protein_codingNFATC1NoNo4772F5H4S8
O95644
TVIS44004693HTLV-1ENSG00000131196.18protein_codingNFATC1NoNo4772F5H4S8
O95644
TCGA Plot Options ▼
Drug Information ▼
GeneNFATC1
DrugBank IDDB00852
Drug NamePseudoephedrine
Target IDBE0004878
UniProt IDO95644
Regulation Typeinhibitor
PubMed IDs21631396
CitationsFiebich BL, Collado JA, Stratz C, Valina C, Hochholzer W, Munoz E, Bellido LM: Pseudoephedrine inhibits T-cell activation by targeting NF-kappaB, NFAT and AP-1 signaling pathways. Immunopharmacol Immunotoxicol. 2012 Feb;34(1):98-106. doi: 10.3109/08923973.2011.582118. Epub 2011 Jun 2.
GroupsApproved
Direct ClassificationPhenylpropanes
SMILESCN[C@@H](C)[C@@H](O)C1=CC=CC=C1
Pathways
PharmGKBPA451170
ChEMBLCHEMBL1590